Randomized, Placebo-controlled, Parallel-group Study in Healthy Male Subjects to Investigate the Pharmacodynamics During the Switching Procedure From Warfarin to Rivaroxaban.

Trial Profile

Randomized, Placebo-controlled, Parallel-group Study in Healthy Male Subjects to Investigate the Pharmacodynamics During the Switching Procedure From Warfarin to Rivaroxaban.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jul 2014

At a glance

  • Drugs Rivaroxaban (Primary) ; Vitamin K; Warfarin
  • Indications Venous thrombosis
  • Focus Pharmacodynamics; Pharmacogenomic
  • Sponsors Bayer
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Feb 2014 Results published in the British Journal of Clinical Pharmacology.
    • 17 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top